Race for coronavirus treatment - As the global race continues to try and find a treatment for coronavirus the UK biotech firm Synairgen is reportedly planning to trial its experimental lung drug on Covid-19 patients.
The company received the green light from UK regulators to conduct a trial of its lead drug SNG001 at NHS trusts across the country.
The inhaled drug has been in development as a treatment for chronic-obstructive pulmonary disorder (COPD), a severe lung disease, but this has been paused to conduct testing on 100 patients who have been diagnosed with Covid-19.
It was identified in a WHO analysis of potential treatments against the coronavirus. Patients can self-administer it, through a small hand-held battery-operated nebulizer.
The trial is due to start next week.
This week, find out more about the Historic Monaco Grand Prix.
Read More
Several French supermarkets have recalled several pasta, rice, prawns and couscous products for health reasons....
Read More
French Prime Minister Jean Castex is to hold a press conference this evening at 6pm to outline the gradual lifting of restrictions as planned by the g...
Read More
With just over two weeks left of confinement, plans are being put in place to slowly re-open the Cote d’Azur and the country as a whole. From the begi...
Read More
